TASE Stock Loans in Israel

Tel Aviv Stock Exchange is the principal cash-equity venue of Israel. Founded in 1953, it operates under the oversight of Israel Securities Authority (ISA), and its leading benchmarks are TA-35, TA-125, TA SME 60. Listing standards are set out in the TASE Rules and Regulations; Israeli Securities Law.

TASE at a glance:

The principal Israeli equities venue, with a substantial overlap with US-listed dual-listed Israeli technology and biotechnology issuers. The dual-listing regime materially affects structuring for technology positions.

On TASE specifically, eligibility turns on where the name sits in the market’s liquidity and on how it is listed. TA-35 and TA-125 constituents carry the free float and daily turnover that support a higher loan-to-value; TA SME 60 and TASE UP issuers are financed more selectively. A large share of the technology and biotechnology names are dual-listed — carrying a primary quote on Nasdaq, the NYSE or the LSE and reporting under that foreign regime — which affects where the shares custody, how the pledge is documented and which disclosure rules bite. Short selling generally requires the position to be covered by a securities-lending transaction, a useful read on which lines the market treats as borrowable.

The principal regulatory reference on TASE is Securities Law. How it applies to any single transaction — reporting levels, step thresholds — turns on the underlying rules and national-law overlays, which we map against your contemplated transaction at the structuring stage alongside the counsel you appoint.

The citations above are public regulatory references, given for orientation only and not as legal advice. Take independent legal advice in the relevant jurisdiction for any specific transaction.

See the full process →